Search - tctmd.com

Displaying 201 - 220 of 417

Sort: Relevancy | Date

Presentation TCT 2016

Trial Designs For LAA Closure: Potential Regulatory Pathways and Unanswered Questions What FDA Would Like to See

Presenter: Aaron V. Kaplan, Rachel Neubrander, Katherine Wallon

November 01, 2016

Presentation TCT 2016

Surveying the Global Landscape of TAVR Newcomers

Presenter: Ganesh Manoharan, Hendrik Treede, Martin B. Leon

November 01, 2016

Presentation TCT 2016

Xeltis: Design and Clinical Updates

Presenter: Ganesh Manoharan, Hendrik Treede, Christian M. Spaulding

November 01, 2016

Presentation TCT 2016

Centera: Design and Clinical Updates

Presenter: Ganesh Manoharan, Hendrik Treede, Stephen G. Worthley

November 01, 2016

Presentation TCT 2016

Venus A Valve: Design and Clinical Updates

Presenter: Ganesh Manoharan, Hendrik Treede, Hasan Jilaihawi

November 01, 2016

Presentation TCT 2016

The Tricuspid Valve: Challenges for Clinical Investigation

Presenter: Matthew G. Hillebrenner, Michael J. Mack, Rebecca T. Hahn

November 01, 2016

Presentation TCT 2016

Jena Valve: Design and Clinical Updates

Presenter: Ganesh Manoharan, Hendrik Treede

November 01, 2016

Presentation TCT 2016

Learnings From A Pivotal Transcatheter Mitral Device Trial: Can The MVARC/COAPT Paradigm Be Shortened?

Presenter: Matthew G. Hillebrenner, Michael J. Mack, Gregg W. Stone

November 01, 2016

Presentation TCT 2016

Possible Approval Pathways for New Mitral and Tricuspid Valve Therapies

Presenter: Matthew G. Hillebrenner, Michael J. Mack, John C Laschinger

November 01, 2016

Presentation TCT 2016

Which Device and Technique for This Patient?

Presenter: Ganesh Manoharan, Hendrik Treede, Tamim Nazif, Torsten P. Vahl

November 01, 2016

Presentation TCT 2016

Spectrum and Assessment of TAVR Accessory Devices (Valvuloplasty Balloons, Neuroprotection Systems, and More)

Presenter: Nicole Ibrahim, Martin B. Leon

November 01, 2016

Presentation TCT 2016

Accurate: Design Features, Special Attributes, and Clinical Trial Program

Presenter: Eberhard Grube, James B. Hermiller Jr., Helge Möllmann

November 01, 2016

Presentation TCT 2016

Valve Degeneration and Mobility Considerations: Assessing Clinical Relevance

Presenter: Nicole Ibrahim, Martin B. Leon, Raj Makkar

November 01, 2016

News Conference News TCT 2016

Midterm Durability of TAVR Valves: PARTNER, Other Studies Boost Confidence

Todd Neale

November 01, 2016

Presentation TCT 2016

Direct Flow: Design Features, Special Attributes, and Clinical Trial Program

Presenter: Eberhard Grube, James B. Hermiller Jr., Azeem Latib

November 01, 2016

News Industry News TCT 2016

Long-Term Study Results Show that PFO Closure is More Effective Than Medical Management in Preventing Recurrent Stroke

November 01, 2016

Presentation TCT 2016

FDA Perspectives on TAVR Label Expansion (E.G. Lower Risk Patients, Bicuspid Aortic Stenosis and Aortic Insufficiency), and New and Iterative Device Approval Pathways

Presenter: Nicole Ibrahim, Martin B. Leon, Jaime Raben

November 01, 2016

Presentation TCT 2016

Lotus and EDGE: Design Features, Special Attributes, and Clinical Trial Program

Presenter: Eberhard Grube, James B. Hermiller Jr., Ted Feldman

November 01, 2016

Presentation TCT 2016

Portico: Design Features, Special Attributes, and Clinical Trial Program

Presenter: Eberhard Grube, James B. Hermiller Jr., Raj Makkar

November 01, 2016

Presentation TCT 2016

Evolut R and 2.0: Design Features, Special Attributes, and Clinical Trial Program

Presenter: Eberhard Grube, James B. Hermiller Jr., Jeffrey J. Popma

November 01, 2016

Advertisement

Trial Designs For LAA Closure: Potential Regulatory Pathways and Unanswered Questions What FDA Would Like to See

Surveying the Global Landscape of TAVR Newcomers

Xeltis: Design and Clinical Updates

Centera: Design and Clinical Updates

Venus A Valve: Design and Clinical Updates

The Tricuspid Valve: Challenges for Clinical Investigation

Jena Valve: Design and Clinical Updates

Learnings From A Pivotal Transcatheter Mitral Device Trial: Can The MVARC/COAPT Paradigm Be Shortened?

Possible Approval Pathways for New Mitral and Tricuspid Valve Therapies

Which Device and Technique for This Patient?

Spectrum and Assessment of TAVR Accessory Devices (Valvuloplasty Balloons, Neuroprotection Systems, and More)

Accurate: Design Features, Special Attributes, and Clinical Trial Program

Valve Degeneration and Mobility Considerations: Assessing Clinical Relevance

Midterm Durability of TAVR Valves: PARTNER, Other Studies Boost Confidence

Direct Flow: Design Features, Special Attributes, and Clinical Trial Program

Long-Term Study Results Show that PFO Closure is More Effective Than Medical Management in Preventing Recurrent Stroke

FDA Perspectives on TAVR Label Expansion (E.G. Lower Risk Patients, Bicuspid Aortic Stenosis and Aortic Insufficiency), and New and Iterative Device Approval Pathways

Lotus and EDGE: Design Features, Special Attributes, and Clinical Trial Program

Portico: Design Features, Special Attributes, and Clinical Trial Program

Evolut R and 2.0: Design Features, Special Attributes, and Clinical Trial Program

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content